ClinicalTrials.Veeva

Menu

Prospective Evaluation of a Commercially Available Hydrogel Spacer (BP-008)

B

BioProtect

Status

Completed

Conditions

Prostate Cancer

Treatments

Other: Observation

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Dosimetry efficacy evaluation of the hydrogel spacer

Full description

Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in 20 males undergoing radiotherapy to treat prostate cancer. Study will utilize pre and post gel insertion CT images to determine the endpoints.

Enrollment

20 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males
  • At lease 18 years of age
  • Undergoing external beam or brachy radiation therapy with a hydrogel spacer

Exclusion criteria

  • Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension

Trial design

20 participants in 1 patient group

Radiation with Hydrogel Spacer
Description:
Males at least 18 years of age, who will be undergoing radiation therapy with a hydrogel spacer in place.
Treatment:
Other: Observation

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems